Details of the Drug

General Information of Drug (ID: DMJW59N)

• Drug Name: Spheramine

Indication

Disease Entry	ICD 11	Status	REF
Parkinson disease	8A00.0	Phase 2	[1]

• Cross-matching ID: TTD ID: D03LKU

References

• [1] ClinicalTrials.gov (NCT00206687) STEPS Trial - Spheramine Safety and Efficacy Study. U.S. National Institutes of Health.